Saterinone, dobutamine, and sodium nitroprusside: Comparison of cardiovascular profiles in patients with congestive heart failure

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 4, 1998, Pages 629-636

  Kieback, A G ^a   Iven, H ^b   Stolzenburg, K ^c   Baumann, G ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

Dobutamine; Heart failure; Hemodynamics; PDE III inhibitors; Saterinone; Sodium nitroprusside

Indexed keywords

DOBUTAMINE; NITROPRUSSIDE SODIUM; PHOSPHODIESTERASE INHIBITOR; SATERINONE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HEADACHE; HEART ARRHYTHMIA; HEART INDEX; HEART MUSCLE OXYGEN CONSUMPTION; HEART STROKE VOLUME; HUMAN; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; LUNG CAPILLARY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUS TACHYCARDIA; STARLING LAW; SYSTEMIC VASCULAR RESISTANCE; VASODILATATION;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; CARDIOTONIC AGENTS; CATHETERIZATION, SWAN-GANZ; DOBUTAMINE; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NITROPRUSSIDE; OXYGEN CONSUMPTION; PHOSPHODIESTERASE INHIBITORS; PIPERAZINES; PYRIDONES;

EID: 0031691835     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199810000-00016     Document Type: Article

References (18)

1. Ross J Jr. Mechanisms of cardiac contraction: what roles for preload, afterload and inotropic state in heart failure? Eur Heart J 1983;4(suppl A):19-28.
2. Ross J Jr, Covell JW, Sonnenblick EH, Braunwald E. Contractile state of the heart characterised by force-velocity relations in variability afterloaded and isovolumic beats. Circ Res 1966;149-62.
3. MacGregor DC, Covell JW, Mahler F, Dilley RB, Ross J Jr. Relation between afterload, stroke volume and descending limb of Starling's curve. Am J Physiol 1974;227:884-90.
4. Pouleur H, Covell JW, Ross J Jr. Effects of nitroprusside on venous return and central blood volume in the absence and presence of acute heart failure. Circulation 1980;61(2):328-37.
5. Sonnenblick EH, Downing SE. Afterload as a primary determinant or ventricular performance. Am J Physiol 1963;204:604-10.
6. Iven H, Djonlagic H. Pharmacokinetics and pharmacodynamics of saterinone in 12 healthy volunteers after i.v. infusion, and bioavailability from tablets [Abstract]. Naunyn Schmiedebergs Arch Pharmacol 1988;338(suppl):R77.
7. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the cooperative North Scandinavian enalapril survival study (CONSENSUS). N Engl J Med 1987;316:1429-35.
8. Cohn JN, Archibald DG, Ziesche S, et al. Effect of cardiovascular therapy on mortality in chronic congestive heart failure: results of 1986;314:1547-52.
9. Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991;325-303-10.
10. Kitamura K, Jorgensen CR, Gobel FL, Taylor HL, Wang Y. Hemodynamic correlates of myocardial oxygen consumption during upright exercise. J Appl Physiol 1972;32:516-22.
11. Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and beta-adrenergic receptor density in failing human hearts. N Engl J Med 1982;307:205-11.
12. Bristow MR. Myocardial β-adrenergic receptor downregulation in heart failure. Int J Cardiol 1984;5:648-52.
13. Baumann G, Felix SB, Filcek SAL. Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output. Am J Cardiol 1990;65:748-54.
14. Baumann G, Ningel K, Permanetter B. Cardiovascular profile of UDCG 115 BS-pimobendane and reversibility of catecholamine subsensitivity in severe congestive heart failure secondary to idiopathic dilated cardiomyopathy. J Cardiovasc Pharmacol 1989;13:730-8.
15. Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991;325:1468-75.
16. DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989;320:677-83.
17. Mager G, Klocke RK, Volkmann A, Kux A, Höpp HW, Hilger HH. Hemodynamics during dobutamine and subsequent milrinone infusion in patients with severe congestive heart failure. Z Kardiol 1991;80:149-57.
18. Dies F, Krell MJ, Whitlow P, et al. Intermittent dobutamine in ambulatory outpatients with chronic heart failure [Abstract]. Circulation 1986;74(suppl II):II-38.